دكساميسين

Pays: Israël

Langue: arabe

Source: Ministry of Health

Ingrédients actifs:

DEXAMETHASONE AS SODIUM PHOSPHATE 1 MG/ML; NEOMYCIN AS SULFATE 5 MG/ML

Disponible depuis:

TEVA PHARMACEUTICAL INDUST.LTD

Code ATC:

S03AA01

forme pharmaceutique:

OPHTHALMIC SOLUTION

Mode d'administration:

OCULAR

Fabriqué par:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Groupe thérapeutique:

NEOMYCIN

indications thérapeutiques:

Steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.

Date de l'autorisation:

2010-10-01